Current Clinical Trials
Department: Oncology
Diagnosis: Lung- Non-Small Cell
Principal Investigator: O'Brien M.D., Edward Thomas
Sub-Investigator(s):
Sponsor: ECOG
Indentifier #: NCT00324805
Title: E1505, A Phase III Randomized Trial of Adjuvant Chemotherapy With or Without Bevacizumab for Patients With Completely Resected Stage IB (> 4 cm) -IIIA Non-Small Cell Lung Cancer (NSCLC)
Department: Cardiology
Diagnosis: Cardiac - Miscellaneous
Principal Investigator: Sporn M.D., Daniel
Sub-Investigator(s):
Sponsor: PLC
Indentifier #: NCT01456013
Title: A Study to Evaluate RenalGuard® System Safety & Efficacy When Compared With Standard Care in the Prevention of Contrast Induced NephRopathy in the SettinG of a Catheterization Laboratory
Department: Oncology
Diagnosis: Melanoma
Principal Investigator: O'Brien M.D., Edward Thomas
Sub-Investigator(s):
Sponsor: ECOG
Indentifier #: NCT01274338
Title: E1609, A Phase III Randomized Study of Adjuvant Ipilimumab Anti-CTLA4 Therapy Versus High-Dose Interferon Alpha-2b for Resected High-risk Melanoma
Department: Oncology
Diagnosis: Genito-urinary - Renal
Principal Investigator: O'Brien M.D., Edward Thomas
Sub-Investigator(s):
Sponsor: SWOG
Indentifier #: NCT01120249
Title: S0931, EVEREST: EVErolimus for Renal Cancer Ensuing Surgical Therapy, A Phase III Study
Department: Oncology
Diagnosis: Lung- Non-Small Cell
Principal Investigator: Lash MD, Bradley
Sub-Investigator(s):
Sponsor: ECOG
Indentifier #: NCT01107626
Title: E5508, Randomized Phase III Study of Maintenance Therapy with Bevacizumab, Pemetrexed, or a Combination of Bevacizumab and Pemetrexed Following Carboplatin, Paclitaxel and Bevacizumab for Advanced Non-Squamous NSCLC